检索结果 - Takuji Okusaka
- Showing 1 - 20 results of 95
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT) 由 Junki Mizusawa, Chigusa Morizane, Takuji Okusaka, Hiroshi Katayama, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse
出版 2016Artigo -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT) 由 Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, Junki Mizusawa, Junko Eba, Takuji Okusaka, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse
出版 2018Artigo -
18
-
19
-
20
相关主题
Internal medicine
Medicine
Cancer
Oncology
Gastroenterology
Chemotherapy
Pancreatic cancer
Gemcitabine
Hepatocellular carcinoma
Pathology
Randomized controlled trial
Clinical endpoint
Adverse effect
Phases of clinical research
Confidence interval
Surgery
Clinical trial
Biology
Sorafenib
Hazard ratio
Colorectal cancer
Alternative medicine
Placebo
Biochemistry
Gene
Carcinoma
Regimen
Toxicity
Biliary tract cancer
Cisplatin